Articles
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate molecules...
Drug Research
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New...
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. announced that King has resubmitted a New Drug Application (NDA) for REMOXY® (oxycodone) to the U.S. Food and...
Drug Research
King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New...
King Pharmaceuticals®, Inc. and Acura Pharmaceuticals, Inc. announced that King has submitted a New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets to the U.S....
Drug Research
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
Pfizer Inc. announced that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39 percent) experienced a...
Articles
Bottlenecks in vaccine development: Eliminate from the beginning
Promising vaccine candidates, rising global demand and preparations for the next pandemic influenza have brought vaccine’s role into focus in the past years and...
Drug Research
New technique to speed up drug development
Scientists working at the European Molecular Biology Laboratory in Grenoble, France have developed a new technique that enables them to introduce up to 15 fluorescent...
Drug Research
Optimer Pharmaceuticals Completes New Drug Application for Fidaxomicin
Optimer Pharmaceuticals, Inc.announced that it has completed the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.